With biosimilars taking on an increasingly prominent role in the US, Biosimilars Forum leader Julie Reed believes that they can offer a “ready-made solution” to current healthcare pressures.
Reed Sets Out Priorities For US Biosimilars Forum
New Executive Director Julie Reed Also Highlights Benefits Of Diverse Membership
In an exclusive interview with Generics Bulletin, the Biosimilars Forum’s executive director Julie Reed sets out the group’s priorities and explains how its diverse membership is helping to position it as a leading voice for the US biosimilars industry.
